Spine

Product

Procedure

The AlloSync bone grafting solutions line is a comprehensive offering of advanced DBMs for various bone grafting needs. AlloSync bone grafts contain osteoconductive and osteoinductive properties, providing the optimal signaling and scaffold for bone remodeling.
The unique geometry of AlloSync Expand 100% demineralized bone is ideal for intraoperative handling and controlled expansion into bone voids. AlloSync Expand fibers come preloaded in a syringe that allows for consistent hydration of the graft with biologic fluids, such as bone marrow aspirate (BMA).
AlloSync Pure DBM is derived from 100% demineralized cortical bone with no extrinsic carriers. When prepared, AlloSync Pure DBM will resist irrigation and can be used in a fluid environment. The clinician can control the handling properties of AlloSync Pure DBM, including decreasing viscosity of for injectable applications or increasing viscosity to add autograft bone. AlloSync bone grafts can be hydrated with fluids including platelet-rich plasma or concentrated BMA.

AlloSync™ Bone Grafting Solutions

Arthrocell is a viable bone allograft that contains cellular, scaffold, and gel components derived from human bone. The microparticulate scaffold is comprised of a proprietary blend of cortical and cancellous allograft bone. The bone-derived gel component provides optimal handling and resists irrigation. The cellular component consists of mesenchymal stem cells (MSCs), osteoprogenitor cells and pluripotent cells.

ArthroCell™ Viable Bone

The BoneSync™ filler portfolio provides surgeons with several bone void solutions with excellent handling characteristics. These products provide an osteoconductive scaffold and can be hydrated with biologic fluids such as bone marrow aspirate to optimize bone remodeling potential.1,2
The BoneSync portfolio includes:
<ul>
 <li>BoneSync putty</li>
 <li>BoneSync strips</li>
</ul>
References
1. Cho AR, Kim HK, Kwon JY, Kim TK, Choi YM, Kim KH. Pain Physician J. 2014;17(6):E737-E745.
2. Chen JC, Ko CL, Shih CJ, Tien YC, Chen WC. J Dent. 2012;40(2):114-122. doi: 10.1016/j.jdent.2011.11.003.

BoneSync™ Putty and Strips

The GraftNet XL bone collection device allows for efficient and large volume collection of autologous bone. With unique features that allow for efficient OR workflow integration and quick access to autologous bone, the GraftNet XL device is ideal for any spinal fusion procedure.

GraftNet™ XL Bone Collection Device

The OsteoAuger™ Bone Graft Harvesting System provides surgeons with an efficient way to recover autogenous, morselized bone from various harvest sites including the calcaneus, distal and proximal tibia, iliac crest, and distal radius. These harvesters are sterile, single-use systems that are available in diameters of 6 mm, 8 mm, and 10 mm. The autogenous morselized bone can be packed into fusion or fracture sites to enhance bone healing and remodeling.

OsteoAuger™ Bone Graft Harvesting System

Bone Repair

Human

Primary (B)

The Angel cPRP and bone marrow processing system uses a proprietary platelet sensor and 1-button automation to deliver customized platelet-rich plasma (PRP) concentrate from bone marrow aspirate (BMA). Bone marrow is a rich source of platelets and nucleated progenitor cells. The Angel device is the only one to provide PRP concentrate from BMA with adjustable cellular levels.

Angel® cPRP and Bone Marrow Processing System

The Vortex™ threaded recovery needle is ideal for maximizing the concentration of osteoprogenitor cells harvested during bone marrow aspiration.1 The unique designs of the threaded tip and vent holes allow the user to easily and accurately reposition the tip of the needle within the bone for optimal aspiration volume.
Patent pending
Reference
1. McLain RF, Boehm CA, Rufo-Smith C, Muschler GF. Transpedicular aspiration of osteoprogenitor cells from the vertebral body: progenitor cell concentrations affected by serial aspiration. Spine J. 2009;9(12):995-100

Spine Vortex™ Threaded Recovery Needles

The Arthrex ACP double-syringe system is used to facilitate the safe and rapid preparation of autologous platelet-rich plasma (PRP) from a small sample of blood at the patient’s point of care. The PRP can be mixed with autograft and allograft bone prior to application to an orthopedic surgical site as deemed necessary by the clinical use requirements. There has been increased interest in autologous blood products for use in a number of orthopedic therapies.

Arthrex ACP® Double-Syringe System

The Arthrex ACP double-syringe system is used to facilitate the safe and rapid preparation of autologous platelet-rich plasma (PRP) from a small sample of blood at the patient’s point of care.

The ACP Max™ system allows for collection of 30 mL, 60 mL, or 90 mL of whole blood for the preparation of platelet-rich plasma (PRP). Using a double-spin regimen, this buffy–coat-based system creates a PRP solution depleted of red blood cells and granulocytes, including neutrophils.1 Additional whole blood in the ACP Max PRP system encourages a more concentrated PRP solution and has the capability to create platelet concentrations up to 11 times higher than whole blood alone.1
 
Reference
1. Arthrex, Inc. Data on file (APT-5535). Naples, FL; 2022.

Fusion Support

Bone Repair

Cellular Therapies